Mild hyperhomocysteinemia is a risk-factor in all etiological subtypes of stroke.

Saved in:

Bibliographic Details
Title:	Mild hyperhomocysteinemia is a risk-factor in all etiological subtypes of stroke.
Authors:	Parnetti, L., Caso, V., Santucci, A., Corea, F., Lanari, A., Floridi, A., Conte, C., Bottiglieri, T.
Source:	Neurological Sciences. Apr2004, Vol. 25 Issue 1, p13-17. 5p.
Subjects:	Homocysteine, Vascular diseases, Chromatographic analysis, Cerebrovascular disease patients, Hyperlipidemia, Lipid metabolism disorders
Abstract:	The role of hyperhomocysteinemia as independent risk factor for stroke needs to be confirmed. The aims of our study were to assess (i) the association between risk of stroke and increasing values of plasma homocysteine and (ii) the interaction between mild hyperhomocysteinemia and conventional vascular risk factors. We studied 161 consecutive patients with first-ever ischemic stroke classified using TOAST criteria and 152 neurologically healthy controls. Homocysteine was measured using high performance liquid chromatography (HPLC). Homocysteinemia was elevated in all stroke subtypes: 13.0±2.5 µmol/l in patients with cardioembolic disease, 13.9±5.4 µmol/l in those with small vessel diseases, 15.5±6.8 µmol/l in cases of undetermined stroke, and 17.8±13.5 µmol/l in patients with large vessel disease. Mean homocysteinemia was 8.10 µmol/l (SD=2.5) in controls. The logistic regression analysis showed that important independent risk factors for ischemic stroke were hypertension (p<0.0001; OR= 3.205; 95% CI, 1.788–5.742), hyperhomocysteinemia (p<0.0001; OR=1.425; 95% CI, 1.300–1562) and hyperlipidemia (p=0.018; OR=2.243; 95% CI, 1.147–4.385). Hyperhomocyst(e)inemia is an independent risk factor for all stroke subtypes and should be routinely measured and treated in stroke patients. [ABSTRACT FROM AUTHOR]
	Copyright of Neurological Sciences is the property of Springer Nature and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database:	Psychology and Behavioral Sciences Collection

Description
Abstract:	The role of hyperhomocysteinemia as independent risk factor for stroke needs to be confirmed. The aims of our study were to assess (i) the association between risk of stroke and increasing values of plasma homocysteine and (ii) the interaction between mild hyperhomocysteinemia and conventional vascular risk factors. We studied 161 consecutive patients with first-ever ischemic stroke classified using TOAST criteria and 152 neurologically healthy controls. Homocysteine was measured using high performance liquid chromatography (HPLC). Homocysteinemia was elevated in all stroke subtypes: 13.0±2.5 µmol/l in patients with cardioembolic disease, 13.9±5.4 µmol/l in those with small vessel diseases, 15.5±6.8 µmol/l in cases of undetermined stroke, and 17.8±13.5 µmol/l in patients with large vessel disease. Mean homocysteinemia was 8.10 µmol/l (SD=2.5) in controls. The logistic regression analysis showed that important independent risk factors for ischemic stroke were hypertension (p<0.0001; OR= 3.205; 95% CI, 1.788–5.742), hyperhomocysteinemia (p<0.0001; OR=1.425; 95% CI, 1.300–1562) and hyperlipidemia (p=0.018; OR=2.243; 95% CI, 1.147–4.385). Hyperhomocyst(e)inemia is an independent risk factor for all stroke subtypes and should be routinely measured and treated in stroke patients. [ABSTRACT FROM AUTHOR]
ISSN:	15901874
DOI:	10.1007/s10072-004-0219-5